Marc Better, VP, Product Sciences at Kite Pharma, Inc. (KITE), sold 9,000 shares at $50.10 ($456K) on 2015-05-01, disclosed to the SEC on 2015-05-05.
Scheduled sale ($456k) by VP, Product Sciences under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.10 | 4,156 | $208K | 45.6% |
| 2 | $51.00 | 3,616 | $184K | 40.4% |
| 3 | $51.97 | 1,228 | $64K | 14.0% |
| Total | $50.72 avg | 9,000 | $456K | 100% |
| Filing → |
| KITE | SELL | 2015-12-03 | $687K | — | Filing → |
| KITE | SELL | 2015-11-04 | $640K | — | Filing → |
| KITE | SELL | 2015-10-02 | $493K | — | Filing → |